Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSX:TINY
TSX:TINYSoftware

Tiny (TSX:TINY) Q3 Breakeven EPS Tests Bearish Profitability Narratives

Tiny (TSX:TINY) has just posted its FY 2025 third quarter numbers, reporting revenue of CA$54.0 million and basic EPS of CA$0.00, alongside trailing twelve month revenue of CA$199.6 million and a net loss of CA$20.5 million. Over recent quarters the company has seen revenue move from CA$51.0 million in FY 2024 Q2 to CA$46.7 million in Q3 and CA$47.6 million in Q4, then CA$48.1 million, CA$50.0 million and now CA$54.0 million in FY 2025 Q3. Quarterly EPS has ranged from a loss of CA$1.17 to a...
NasdaqGM:RZLV
NasdaqGM:RZLVSoftware

Rezolve AI’s Reward Loyalty Deal Recasts 2026 Growth And Profit Focus

Rezolve AI announced a $230 million all-cash acquisition of Reward Loyalty UK Limited, a provider of loyalty and rewards solutions. The company framed the deal as non dilutive and EBITDA accretive, with an updated outlook for 2026 revenue and annual recurring revenue targets. Management highlighted the potential for broader reach across banking and retail channels following the acquisition and guidance update. Rezolve AI, listed on NasdaqGM:RZLV, is drawing fresh attention with this...
NYSE:SEI
NYSE:SEIEnergy Services

A Look At Solaris Energy Infrastructure (SEI) Valuation After Recent Short Term Share Price Weakness

Solaris Energy Infrastructure stock triggered by recent performance metrics Solaris Energy Infrastructure (SEI) has drawn fresh attention after recent performance data showed a 1 day return of an 8.63% decline, a 7 day return of a 13.21% decline, and a month gain of 6.47%. See our latest analysis for Solaris Energy Infrastructure. Despite the recent 1 day and 7 day share price declines, Solaris Energy Infrastructure’s 90 day share price return of 14.62% and very large 3 year total shareholder...
ENXTPA:ABVX
ENXTPA:ABVXBiotechs

A Look At Abivax (ENXTPA:ABVX) Valuation After Wider Losses Trial Progress And Index Inclusion

ABIVAX Société Anonyme (ENXTPA:ABVX) is in focus after full year 2025 earnings showed revenue of €4.57 million and a net loss of €336.1 million, alongside fresh trial, leadership, financing, and index inclusion updates. See our latest analysis for ABIVAX Société Anonyme. The recent earnings release, positive Phase 3 safety update, leadership hires, ESOP related shelf registration, and FTSE All World Index inclusion come against a backdrop of a 1 year total shareholder return above 10x. At the...
NasdaqCM:AXGN
NasdaqCM:AXGNMedical Equipment

Is It Too Late To Consider Axogen (AXGN) After Its 75% One Year Surge?

Wondering if Axogen at around US$31.32 is still offering value or if the easy gains are behind it? This article walks through what the current price actually reflects. The stock has had a mixed recent run, with a 4.0% decline over the last week and a 1.3% decline over the last month, while still sitting on a 1.0% return year to date and a 75.9% return over the last year. Those moves sit within a longer track record that includes a 223.2% return over three years and a 56.8% return over five...
HLSE:VALMT
HLSE:VALMTMachinery

A Look At Valmet Oyj’s Valuation As Leadership And Cost Actions Reshape Its Earnings Story

Valmet Oyj (HLSE:VALMT) is in focus after announcing that CFO Katri Hokkanen will depart by September 2026 and outlining cost-focused changes to its Global Supply operations in Sweden and Poland. See our latest analysis for Valmet Oyj. At a share price of €24.23, Valmet’s 30 day share price return of 14.89% and year to date share price return of 14.32% contrast with a 1 year total shareholder return of 2.07%. This suggests that recent momentum has softened after earlier gains. If you are...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Has Intel (INTC) Run Too Far After Its 81% One Year Share Price Surge?

If you are wondering whether Intel's share price truly reflects what you are getting for your money, this breakdown can help you connect the recent moves in the stock with what the underlying valuation is actually indicating. Intel's stock closed at US$41.19, with a 6.4% decline over the last 7 days and a 9.7% decline over the last 30 days, while still showing a 4.6% gain year to date and an 81.4% return over the last year, compared to a 28.3% return over 3 years and a 31.9% decline over 5...
ENXTPA:ODET
ENXTPA:ODETLogistics

A Look At Compagnie De L'Odet’s Valuation After Softer Results And A Higher Proposed Dividend

Why Compagnie de l'Odet's latest earnings and dividend plans matter Compagnie de l'Odet (ENXTPA:ODET) combined softer full year 2025 results with a proposed higher cash dividend, a mix that gives you fresh information on both business performance and shareholder payout priorities. See our latest analysis for Compagnie de l'Odet. The latest mix of softer 2025 earnings and a higher proposed dividend appears to have supported a short burst of buying interest, with a 7 day share price return of...
NYSE:ZETA
NYSE:ZETASoftware

A Look At Zeta Global Holdings (ZETA) Valuation After The Athena AI Marketing Agent Launch

Why Athena’s launch matters for Zeta Global Holdings (ZETA) shareholders Zeta Global Holdings (ZETA) has moved Athena by Zeta into general availability, giving enterprise marketing teams a conversational AI agent that ties predictive recommendations directly to execution and built-in financial accountability. The launch brings Athena’s Insights and Advisor apps into the Zeta Marketing Platform, offering predictive analytics, workflow automation, and ROI focused guidance across paid, owned,...
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

A Look At Regencell Bioscience Holdings (RGC) Valuation After A US$500 Million At The Market Offering

Regencell Bioscience Holdings (RGC) has filed a US$500 million at the market follow-on equity offering, shortly after registering a shelf for its ordinary shares. This brings potential dilution and funding plans into focus for existing shareholders. See our latest analysis for Regencell Bioscience Holdings. The US$500 million at the market offering comes after a year in which Regencell Bioscience Holdings has seen a very large 1 year total shareholder return, even though the 30 day share...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

Is It Too Late To Consider Robinhood Markets (HOOD) After The Recent Share Price Pullback?

If you are wondering whether Robinhood Markets at around US$65 a share is still attractively priced or already reflects most of the story, this breakdown will help you compare the current price with the underlying value. The stock has recently pulled back, with a 5.7% decline over the last 7 days and a 14.1% decline over the last 30 days, even after a 54.6% return over the past year and a very large 3-year gain. Recent headlines have focused on Robinhood's role in retail trading, regulatory...
NYSE:GE
NYSE:GEAerospace & Defense

Shareholder Campaign On GE Israel Ties And What It Means For Investors

A shareholder coalition led by JLens and the Anti-Defamation League is urging GE Aerospace investors to vote against Proposal 7 at the upcoming annual meeting. Proposal 7 requests an independent report on NYSE:GE's due diligence around supplying defense products to the Israel Defense Forces, citing human rights concerns. GE's Board recommends voting against the proposal, citing potential risks to the defense business and wider reputational and operational impacts. The debate highlights...
NYSE:BA
NYSE:BAAerospace & Defense

Boeing’s E‑3 Loss Puts Defense Role And Valuation In Sharp Focus

An E-3 Sentry AWACS aircraft was lost in a recent Middle East conflict following an Iranian attack. The incident highlights pressures on the limited U.S. fleet of airborne early warning planes. Boeing (NYSE:BA) manufactures both the aging E-3 Sentry and its proposed E-7 Wedgetail replacement. For anyone following Boeing, this incident draws attention to its defense and surveillance business, not just its commercial jets. The E-3 Sentry loss underscores how much the U.S. relies on older...
NYSE:HUN
NYSE:HUNChemicals

Is Huntsman (HUN) Using Hungary Expansion To Quietly Reposition Its European Specialty Portfolio?

Huntsman Corporation has opened its expanded Performance Products manufacturing facility in Petfurdo, Hungary, boosting global capacity for polyurethane, coatings, metalworking, and electronics markets with support from a Hungarian government investment grant. This enlargement strengthens Huntsman’s European production footprint and suggests greater operational flexibility to serve higher-value specialty applications across multiple industrial end markets. Next, we’ll examine how this...
NYSE:SLG
NYSE:SLGOffice REITs

Does SL Green (SLG)ʼs One Madison Refinancing Reveal a Shift in Its Office Risk Strategy?

SL Green Realty Corp. and its partners recently completed a US$1.65 billion, five-year fixed-rate refinancing of One Madison Avenue via a single-asset, single-borrower CMBS execution, replacing the prior US$1.25 billion construction facility with a US$1.171 billion outstanding balance. This refinancing, led by major global banks and reportedly the largest U.S. office CMBS issuance over the past year, underlines lender appetite for prime Manhattan office assets in a challenged broader office...
NasdaqGS:FITB
NasdaqGS:FITBBanks

A Look At Fifth Third Bancorp (FITB) Valuation After Recent Share Price Pullback

Context for Fifth Third Bancorp’s Recent Share Performance Fifth Third Bancorp (FITB) has drawn attention after a one-month return of a 9.68% decline and a past three-month return of a 5.9962% decline. This has prompted investors to reassess the regional bank’s recent share performance and fundamentals. See our latest analysis for Fifth Third Bancorp. At a share price of US$44.68, Fifth Third Bancorp’s recent one month share price return of a 9.68% decline and year to date share price return...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

A Look At TMC The Metals (TMC) Valuation After Sharp Recent Share Price Declines

TMC the metals (TMC) has drawn investor attention after recent trading pressure, with the share price showing declines over the past week, month, and past 3 months. That volatility is prompting closer scrutiny of its fundamentals. See our latest analysis for TMC the metals. That short term weakness, including a 1 day share price return of 3.98% decline and a 30 day share price return of 34.61% decline at a latest share price of $4.10, sits alongside a very large 1 year total shareholder...
SEHK:2616
SEHK:2616Biotechs

A Look At CStone Pharmaceuticals (SEHK:2616) Valuation After Encouraging CS2009 Trial Results And Wider Losses

CStone Pharmaceuticals (SEHK:2616) has drawn fresh attention after reporting detailed Phase I/II data for CS2009, its trispecific antibody, alongside full year 2025 results that show CNY 269.58 million in sales and a CNY 437 million net loss. See our latest analysis for CStone Pharmaceuticals. The encouraging CS2009 data appears to be feeding into a strong shift in sentiment, with a 1 day share price return of 5.04% and a 7 day share price return of 40.68% at HK$8.75. Momentum has been...
NYSE:SKT
NYSE:SKTRetail REITs

How Tanger’s Board Shuffle and Governance Award Will Impact Tanger (SKT) Investors

Tanger Inc. recently announced that long-time Chair Steven B. Tanger retired from the Board in May 2026, becoming Chair Emeritus, with independent director Luis Ubiñas stepping in as Non-Executive Chair while Bridget Ryan-Berman ended her role as Lead Independent Director but remained on the Board. Coinciding with these governance changes, Tanger also received Nareit’s 2026 Leader in the Light Award for Transparency, underscoring how board refreshment is occurring alongside external...
NYSE:KVYO
NYSE:KVYOSoftware

Klaviyo (KVYO) Valuation Check After New AI Composer And Customer Agent Upgrades

Klaviyo (KVYO) has drawn fresh attention after unveiling Composer, an AI driven tool that builds full marketing campaigns from a single prompt, along with expanded Customer Agent skills and more than 75 platform updates. See our latest analysis for Klaviyo. The AI product announcements arrive after a mixed stretch for the stock, with a 1 month share price return of 8.96% but a 90 day share price return showing a 41.9% decline and a 1 year total shareholder return showing a 37.31% decline,...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Assessing Tesla (TSLA) Valuation As Shares Pull Back Despite Strong One Year Return

Tesla (TSLA) continues to attract attention as investors weigh its recent share performance against reported revenue of US$94.8b and net income of US$3.8b, along with mixed returns over the past month and past 3 months. See our latest analysis for Tesla. The recent share price pullback, with a 30 day share price return of an 11.73% decline and a 90 day share price return of a 21.82% decline, contrasts with Tesla's 1 year total shareholder return of 37.09%. This suggests that shorter term...
ASX:CHN
ASX:CHNMetals and Mining

ASX Penny Stocks With A$400M Market Cap To Consider

As Australian shares edge towards a minor rise, market participants are closely watching decisions from the Reserve Bank and Fair Work, which could influence investor sentiment. In this context, penny stocks—typically smaller or newer companies—offer intriguing opportunities for those looking beyond established names. Despite being an older term, these stocks can still represent significant potential when backed by strong fundamentals and robust balance sheets.
NYSE:IMAX
NYSE:IMAXEntertainment

Should IMAX’s Global, Local-Language Push Require Action From IMAX (IMAX) Investors?

In recent days, IMAX outlined plans to deepen filmmaker and studio partnerships, evolve its “Filmed for IMAX” program with more flexible exclusivity windows, and accelerate international expansion with an emphasis on local-language content and under-penetrated markets such as India, Japan, Brazil, and parts of Europe. An important implication is that IMAX is positioning itself as a more integral partner in premium theatrical releases while simultaneously broadening its reach beyond Hollywood...
NYSE:RCL
NYSE:RCLHospitality

Has Royal Caribbean (RCL) Pullback Opened A Valuation Opportunity For Long-Term Investors

Investors may be wondering whether Royal Caribbean Cruises, at a last close of US$261.37, is still priced for smooth sailing or already reflects a lot of optimism in the stock. The share price has shown mixed momentum, with a 6.3% decline over 7 days and a 15.9% decline over 30 days, alongside a 29.1% return over 1 year, a very large 3-year return that sits well above 7x, and a 199.9% return over 5 years. Recent headlines around cruise operators have focused on demand resilience, pricing...